Sensitive ASX Announcement

FDA Approves IDE Amendment to AVITA's Vitiligo Pivotal Study

Published: 17/08/21, 08:34am (AEST)3 pages
AVITA Medical, Inc.
AVH:ASXHealthcare

Recent AVH Announcements

Price Sensitive only